Four health tech leaders have been shortlisted for an award following an intensive shortlisting process.
The individuals were selected from the strongest pool of Leader of the Year nominees in the Health Tech World Awards’ four-year history.
Normally only three entries make the cut, but due strength of entries, four will now go on to the next stage.
The entries will be judged by a representative from category sponsor Reddie & Grose, with the winner revealed at a virtual event on October 28.
Reddie & Grose LLP is an internationally renowned firm of European and United Kingdom patent, trade mark and design attorneys.
With an understanding of both the heavily regulated pharmaceutical sector and the fast moving tech sector our team can support healthcare companies in deciding how and why they should protect and utilise their intellectual property.
Working at the intersection of different technologies, regulations and patent law, we support multi-nationals to manage and defend their IP portfolio as well as helping smaller companies navigate the IP landscape and protect their innovations.
Congratulations to the shortlist and thank you to everyone who entered or nominated. This was a tough call!
Leader of the Year Shortlist
Lindsay Davis
With a vision of available, accessible and affordable healthcare for all women in Asia, Davis founded FemTech Association Asia in October 2021 as the region’s first and largest industry network for founders, professionals and investors with a focus on improving women’s health through technology solutions.
The organisation represents 80+ companies across 10 countries in Asia.
FemTech Asia was a Finalist in the GIOF – 2022 Business Inclusivity Awards and is member of the UNFPA Equity 2030 Alliance and a Founding Member of the Milken Institute Women’s Health Network.
Suzy Jackson
Suzy Jackson has built a career spanning both sides of health tech, strategy and execution.
She rose from Analyst to Managing Director at Accenture in ten years, leading its commercial life sciences consulting portfolio and building a $1BN+ CRM Center of Excellence.
She then moved client-side as Chief Commercial Officer of RVO Health, building the company’s pharma direct-to-patient commercial model and go-to-market strategy from scratch in just twelve weeks.
Beyond her commercial achievements, Suzy has been a powerful public voice for women in the industry, sharing her IVF journey to highlight the support women need to stay in their careers and furthers this mission through board and advisory roles with Safe Alliance and Equality Now.
Peter Mountney
Peter Mountney is a rare leader: a scientist with the vision to see how Artificial Intelligence (AI) could change cancer care, and the drive to build the company that made it possible.
Co-founder and CEO of Odin Vision and now Global Vice President of Artificial Intelligence at Olympus, Mountney holds a PhD in AI and Medical Imaging from Imperial College and led AI
and quantum programmes at Siemens Healthineers across Germany, the USA and the UK.
Peter is an Honorary Associate Professor at UCL, a Fellow of the Royal Academy of Engineering Enterprise Hub and a member of the Royal Society Industrial College.
Dr Tom Ratcliffe
Dr Tom Ratcliffe has established himself as a trusted clinical leader in the adoption of digital technology across primary care, combining frontline experience with strategic leadership to ensure innovation delivers meaningful improvements for patients, clinicians and the wider NHS.
As Chief Clinical Information Officer, Clinical Safety Officer, medical director and practising GP at Modality Partnership, he has led the safe development, implementation and scaling of technologies that improve access, reduce clinician burden and modernise healthcare delivery.
One of Tom’s most significant achievements has been leading the clinical deployment of ambient AI through Heidi Health.
He led the evaluation of available solutions, authored the clinical safety case and established the governance framework that enabled deployment across more than 200 clinicians working in 53 GP sites
